Description
Trial categories will include the following:
Major trials of ARBs in primary prevention of hypertension
Major trials of ARBs in secondary prevention of hypertension and target-organ damage
Trials of ARBs that achieve 24-hour control of hypertension
Reducing blood pressure and absolute cardiovascular risk
Major trials of ARBs in secondary prevention of heart failure
Trials of ARBs in hypertensive patients with type 2 diabetes mellitus (diabetic hypertension)
Prevention of the progression of chronic (nondiabetic) kidney disease using ARBs
Prevention of the progression of diabetic nephropathy (diabetic kidney disease) using ARBs
Comparative antihypertensive efficacy trials of ARBs
If you are interested in this title, you might also be interested in the following titles:
The 10-minute consultation: hypertensionQuit Smoking Wheel